Tracking Tregs

The paper: J.D. Fontenot et al., "Regulatory T cell lineage specification by the forkhead transcription factor Foxp3," Immunity, 22:329-41, 2005. (Cited in 217 papers) The finding: Using a GFP-tagged knockin mouse, Alexander Rudensky's group at the University of Washington in Seattle showed that the expression of the transcription factor Foxp3 defines a subset of regulatory T cells involved in suppressing autoimmune activity. The

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:

J.D. Fontenot et al., "Regulatory T cell lineage specification by the forkhead transcription factor Foxp3," Immunity, 22:329-41, 2005. (Cited in 217 papers)

The finding:

Using a GFP-tagged knockin mouse, Alexander Rudensky's group at the University of Washington in Seattle showed that the expression of the transcription factor Foxp3 defines a subset of regulatory T cells involved in suppressing autoimmune activity.

The surprise:

Unlike most other transcription factors, which are expressed in multiple systems or tissues, Foxp3 was found only in a subset of αβ T cells. "It's a very rare instance when there is a dedicated function," Rudensky says. At the time, CD25 expression was the best available marker for identifying regulatory T cells; Foxp3's surprising specificity has since made it a more reliable marker.

The follow-up:

Rudensky and his colleagues found that Foxp3 expression not only defines regulatory T cells, but is also necessary for the suppressor ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies